Concord Drugs Ltd — Important, 30-12-2025: Company Update

Concord Drugs Limited has announced receiving significant domestic purchase orders for various pharmaceutical products during December. These orders, valued at approximately ₹ 14.71 Crores, came from several entities including state medical service corporations and the Directorate General of Health Services. The company expects to execute these orders within 45 to 60 days. This substantial inflow of business exceeds the company's materiality thresholds and is anticipated to have a positive impact on its overall business performance and operational activities, signaling healthy demand for its products.